LoginRegister
    Janssen Pharma bags breakthrough designation for niraparib in prostate cancerJanssen Pharma bags breakthrough designation for niraparib in prostate cancer
    Q BioMed acquires USFDA approved cancer pain drug Strontium-89 ChlorideQ BioMed acquires USFDA approved cancer pain drug Strontium-89 Chloride
    CDSCO approves SCTIMST as Medical Device Testing LabCDSCO approves SCTIMST as Medical Device Testing Lab
    Lupin Mandideep facility red-flagged by USFDA for CGMP violationsLupin Mandideep facility red-flagged by USFDA for CGMP violations
    SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDASPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA
    Lupin unveils generic version of CellCept in USLupin unveils generic version of CellCept in US
    JnJ submits New Drug Application to USFDA for SpravatoJnJ submits New Drug Application to USFDA for Spravato
    Health Ministry, WHO join hands to redesignate NHSRC for development of medical devicesHealth Ministry, WHO join hands to redesignate NHSRC for development of medical devices
    AstraZeneca auto-injector pen Fasenra for asthma treatment gets USFDA green lightAstraZeneca auto-injector pen Fasenra for asthma treatment gets USFDA green light
    Gilead Descovy wins USFDA approval for preventing sexually acquired HIV infectionGilead Descovy wins USFDA approval for preventing sexually acquired HIV infection
    Alembic JV Aleor Derma gets USFDA nod for therapeutic equivalent of Clobex SprayAlembic JV Aleor Derma gets USFDA nod for therapeutic equivalent of Clobex Spray
    Chennai-based Shield Healthcare acquires Brio Bliss Life Science, Nutri SynapzzChennai-based Shield Healthcare acquires Brio Bliss Life Science, Nutri Synapzz
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X